trending Market Intelligence /marketintelligence/en/news-insights/trending/WcmCFvHMRt4qT2aXqrJgfw2 content esgSubNav
In This List

US FDA reports violations at Strides Shasun facility

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


US FDA reports violations at Strides Shasun facility

Strides Shasun Ltd. said the U.S. Food and Drug Administration issued a Form 483 recording three violations at its Bangalore facility in Karnataka, India.

The company said none of the observations were related to data integrity or quality control and it will address them comprehensively.

Strides' flagship Bangalore plant, which underwent the inspection in May, has a host of key products pending approval with the regulator.